Effect of 4-demethoxydaunorubicin (4-DMDR) in chronic myeloid leukemia in blastic transformation and relapsed acute leukemias.
D000380:Agranulocytosis / Q000139:chemically induced; D003630:Daunorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D015255:Idarubicin; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D013921:Thrombocytopenia / Q000139:chemically induced
D015255:Idarubicin; D003630:Daunorubicin